| To: Stock Puppy who wrote (7) | 6/19/1996 2:38:00 PM | | From: Chris Forte | | | | |
Yes, another pretty wild ride to say the least! At one point it was up .563 1.656 x 1.75 on 300,000volume. Not bad! Don't know if it will hold, but the point is, somebody out there noticed little AMDL Inc. Looks like you made a good decision. Lets hope we have a long and successful ride. Chris |
| | AMDL Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: Stock Puppy who wrote () | 6/19/1996 8:12:00 PM | | From: Eduardo Canto | | | |
There is section about AMDL in Small Wonders Research Report (http://www.tiac.net/users/harrison/). Can anyone comment on this and the recent recommendation by Strategic Investment (see small talk at Small Wanders home page), does anyone suscribe to Strategic?
Thanks in advance,
Eduardo Canto |
| | AMDL Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: Eduardo Canto who wrote (12) | 6/22/1996 7:28:00 AM | | From: John Boluyt | | | |
AMDL has it's own WEB page at : amdl.com.
This has a number of different documents you can download
including product and financial information.
I like this stock long term, but had bought this stock for .96 about two weeks ago. When the stock ran up to a $1.50 I sold my position.
I did not feel like I could turn down a 50% profit in two weeks.
I am hoping the stock goes back down to around a dollar so I can
pick up shares again. Did I make a mistake by selling? It seems
most of the run up was caused not by news but exposure... |
| | AMDL Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: John Boluyt who wrote (13) | 6/22/1996 10:25:00 PM | | From: Eduardo Canto | | | |
Mr. Boluyt,
Can't say if you did the right thing or not. I got in at $1 and don't plan to sell until we hit $3 which I don't think will take long. The company is beginning to get some good exposure and I believe there are still some reviews that haven't come out just yet. Their product should bring revenues in soon, particularly from China where the approval process for marketing I hear is moving along well. In addition, they are developing an H. Pylori test kit for which they are preparing to apply for FDA approval.
Good investing,
E.C. |
| | AMDL Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: Stock Puppy who wrote () | 7/25/1997 11:52:00 AM | | From: Stock Puppy | | | |
AMDL, Inc. Files Patent for Novel Cancer Diagnostic System
TUSTIN, Calif., July 24 /PRNewswire/ -- AMDL, Inc. (OTC Bulletin Board: AMDD) today announced that it has filed for patent protection for a novel immunoassay,
Oncochek(TM) which AMDL scientists have developed for the detection of a number of cancers. The assay uses a monoclonal antibody to an octopeptide, and a
polyclonal antibody to measure the level of fibrinogen degradation products, (FDP), in the serum of a cancer patient. FDP level in cancer patients is elevated due to an
increased secretion of protein degrading enzymes by the tumor cells.
Serum from incompletely clotted blood does not appear to cause any problems with the assay. As a result it is not as sensitive to the manner in which the serum sample
is collected, and is less prone to false positive readings. Preliminary findings indicate that FDP levels in serum of cancer patients are elevated. Such findings are
consistent with the widely accepted finding that growing tumors have an increased rate of protease release.
AMDL, Inc. is a biomedical company applying immunochemical technology to develop novel diagnostic tests for use in the diagnosis of cancer and other diseases.
NOTE: Certain statements in this announcement that relate to AMDL, Inc.'s plans, objectives or future performance may be deemed forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations. Actual strategies and results in
future periods may differ materially from those currently expected because of various risks and uncertainties. Additional discussion of factors affecting AMDL, Inc.'s
business and prospects is contained in its periodic filings with the Securities and Exchange Commission. |
| | AMDL Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: Stock Puppy who wrote () | 8/1/1997 1:15:00 PM | | From: Stock Puppy | | | |
AMDL, INC. Announces the Initiation of Commercial Sales
TUSTIN, Calif., Aug. 1 /PRNewswire/ -- AMDL, Inc. (OTCBB:AMDD) today announced that it has received an initial order for its
DR-70 cancer diagnostic kit from China under the recently renegotiated distribution agreement. Sales have also begun in Brazil,
Malaysia and Poland. The orders represent modest income at this time, but mark an important milestone for AMDL in that it is the true
beginning of commercial sales for the company. We are anticipating a very nice ramping up as the company moves forward both with
other products and distributors around the world.
AMDL, Inc. is a biomedical company applying immunochemical technology to develop novel diagnostic tests for use in the diagnosis
of cancer and other diseases.
Note: Certain statements in this announcement that relate to AMDL, Inc.'s plans, objectives or future performance may be deemed
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based on
management's current expectations. Actual strategies and results in future periods may differ materially from those currently expected
because of various risks and uncertainties. Additional discussion of factors affecting AMDL, Inc.'s business and prospects is contained
in its periodic filings with the Securities and Exchange Commission. |
| | AMDL Inc. | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |
